Therefore, in a second series of in vitro experiments we incubated normal human astrocytes (NHAs)26 with CSF sampled from the same AD enrolled for the TMS experiments in order to verify the effects of CSF tau on astrocytes survival. The gene discussed is MAPT; the disease is Alzheimer disease.